H. Bryan Brewer

HDL Therapeutics, Inc. develops cardiovascular devices. It specializes in the field of reversing coronary atherosclerosis. The company was founded by Michael M. Matin and Bryan H. Brewer Jr. and is headquartered in Vero Beach, FL.

Lipid Sciences, Inc. is a biotechnology company that is engaged in research and development of products and processes intended to treat major medical indications such as cardiovascular disease and viral infections in which lipids or fat components, play a key role. The company is focused on applications of technologies in two main areas: cardiovascular disease, using the HDL Therapy platform and viral infections, using the Viral Immunotherapy platform. HDL Therapy focuses on developing treatments for the reversal of atherosclerosis, which is the leading cause of heart attacks, strokes and peripheral vascular disease. It was formerly known as NZ Corp. The company was founded in 1908 and is headquartered in Pleasanton, CA.

MedStar Research Institute provides scientific, administrative, and regulatory support for clinical research. The non-profit company is based in Hyattsville, MD.